These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10025150)

  • 1. [Immunosuppressive therapy in intraocular inflammation. II. Basic principles, indications, contraindications, side-effects].
    Manthey KF
    Ophthalmologe; 1998 Dec; 95(12):846-58. PubMed ID: 10025150
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunosuppressive therapy of intraocular inflammation. I. Basic principles, indications, contraindications, side-effects].
    Manthey KS
    Ophthalmologe; 1998 Nov; 95(11):792-804. PubMed ID: 9857643
    [No Abstract]   [Full Text] [Related]  

  • 3. [Strategies for the immunosuppressive therapy of intraocular inflammation].
    Becker MD
    Ophthalmologe; 2005 Apr; 102(4):341-8. PubMed ID: 15682291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [News on therapies for uveitis].
    de Smet MD
    J Fr Ophtalmol; 2005 May; 28(5):556-61. PubMed ID: 15976726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Classical immunosuppressive agents].
    Martenet AC
    Bull Soc Belge Ophtalmol; 1989; 230():135-41. PubMed ID: 2488429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive therapy with mycophenolate mofetil (CellCept) in treatment of uveitis].
    Zierhut M; Stübiger N; Aboalchamat W; Landenberger H; Bialasiewicz AA; Engelmann K
    Ophthalmologe; 2001 Jul; 98(7):647-51. PubMed ID: 11490743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate in inflammatory eye disease.
    Stawell R
    Ocul Immunol Inflamm; 2003 Jun; 11(2):79-82. PubMed ID: 14533026
    [No Abstract]   [Full Text] [Related]  

  • 8. [Basic principles in treatment of endophthalmitis].
    Kain HL
    Klin Monbl Augenheilkd; 1997 May; 210(5):274-88. PubMed ID: 9324533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease.
    Baker KB; Spurrier NJ; Watkins AS; Smith JR; Rosenbaum JT
    Br J Ophthalmol; 2006 Dec; 90(12):1481-5. PubMed ID: 16914474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil for the treatment of uveitis.
    Teoh SC; Hogan AC; Dick AD; Lee RW
    Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach.
    Simonini G; Paudyal P; Jones GT; Cimaz R; Macfarlane GJ
    Rheumatology (Oxford); 2013 May; 52(5):825-31. PubMed ID: 22879466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil in the treatment of uveitis in children.
    Doycheva D; Deuter C; Stuebiger N; Biester S; Zierhut M
    Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eye and corticosteroid's use].
    Fel A; Aslangul E; Le Jeunne C
    Presse Med; 2012 Apr; 41(4):414-21. PubMed ID: 22377461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TNFalpha inhibitors in the treatment of uveitis].
    Greiner K; Plskova J
    Ophthalmologe; 2005 Apr; 102(4):335-40. PubMed ID: 15690162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory Therapy in Uveitis.
    Tomkins-Netzer O; Talat L; Ismetova F; Samy A; Lightman S
    Dev Ophthalmol; 2016; 55():265-75. PubMed ID: 26501368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive therapy of uveitis with corticosteroids and cytostatic drugs].
    Fekete B; Szegedi G; Szabó G; Petrányi G; Bauer N; Gát L
    Orv Hetil; 1972 Aug; 113(34):2036-41. PubMed ID: 5051435
    [No Abstract]   [Full Text] [Related]  

  • 17. New Immunosuppressive Therapies in Uveitis Treatment.
    Mérida S; Palacios E; Navea A; Bosch-Morell F
    Int J Mol Sci; 2015 Aug; 16(8):18778-95. PubMed ID: 26270662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side-effects of anti-inflammatory therapy in uveitis.
    Uchiyama E; Papaliodis GN; Lobo AM; Sobrin L
    Semin Ophthalmol; 2014; 29(5-6):456-67. PubMed ID: 25325874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF inhibition for ophthalmic indications: current status and outlook.
    Rifkin LM; Birnbaum AD; Goldstein DA
    BioDrugs; 2013 Aug; 27(4):347-57. PubMed ID: 23568177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic mechanisms and the effect of immunosuppressive therapy in ophthalmology].
    Poch T; Ríhová E; Michalová K
    Cesk Oftalmol; 1993 Jun; 49(3):131-8. PubMed ID: 8348646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.